Navigation Links
Some Blood Pressure Drugs Might Help Slow Alzheimer's: Study
Date:9/11/2012

By Steven Reinberg
HealthDay Reporter

TUESDAY, Sept. 11 (HealthDay News) -- Angiotensin receptor blockers, drugs commonly taken to control high blood pressure, appear to reduce the amount of plaque in the brains of Alzheimer's patients and others, a new study shows.

These results were found when patients with high blood pressure on drugs such as losartan (Cozaar) died and underwent an autopsy. These brain plaques are a hallmark of Alzheimer's disease. Whether, however, these drug also improve mental function isn't known, the researchers added.

"[It] would have to be proven in a clinical trial whether these effects seen in an autopsy study manifest themselves in a clinical setting," said lead researcher Dr. Ihab Hajjar, an assistant professor at the University of Southern California Keck School of Medicine. "But since we don't have any treatment for Alzheimer's, it's worth pursuing."

Candesartan (Atacand), irbesartan (Avapro), olmesartan (Benicar), valsartan (Diovan), telmisartan (Micardis) and eprosartan (Teveten) are other angiotensin receptor blockers approved by the U.S. Food and Drug Administration.

Although this study can't determine whether angiotensin receptor blockers improve mental function in Alzheimer's patients, Hajjar pointed out there is a connection between blood pressure and brain health, and the choice of blood-pressure lowering drugs may make a difference in maintaining brain function.

The report was published online in the Sept. 10 issue of the Archives of Neurology.

For the study, Hajjar's team autopsied the brains of 890 patients with hypertension who had been taking various medications to lower their blood pressure. Some of these patients had Alzheimer's disease while others didn't. Some had been diagnosed with dementia but not Alzheimer's. Most were in their 70s or 80s when they died.

Patients taking angiotensin receptor blockers had fewer brain plaques whether or not they had been diagnosed with Alzheimer's, the researchers found.

Moreover, these results were seen only among those who had been taking angiotensin receptor blockers and not among patients taking any other blood pressure medications.

Patients treated with angiotensin receptor blockers had fewer brain plaques than people not treated with any blood pressure drug, the study also found.

"Uncontrolled hypertension is a recognized risk for Alzheimer's disease and for vascular dementia, so this is unsurprising, but highly welcome, news," said Dr. Sam Gandy, the Mount Sinai chair in Alzheimer's Disease Research and associate director of the Mount Sinai Alzheimer's Disease Research Center, in New York City.

Hajjar's team is looking at the effects of this group of drugs in people who Alzheimer's or other forms of dementia. A pilot study found they did slow or prevent decline in areas of the brain that are susceptible to damage from high blood pressure.

While the new study found an association between these blood pressure medicines and levels of brain plaque, it did not prove a cause-and-effect relationship.

More information

For more about Alzheimer's Disease, visit the Alzheimer's Association.

SOURCES: Ihab Hajjar, M.D., assistant professor, Keck School of Medicine, University of Southern California, Los Angeles; Sam Gandy, M.D., Ph.D., Mount Sinai Chair in Alzheimer's Disease Research, professor, neurology and psychiatry, director, Mount Sinai Center for Cognitive Health, and associate director, Mount Sinai Alzheimer's Disease Research Center, Mount Sinai School of Medicine, New York City; Sept. 10, 2012, Archives of Neurology, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Blood Pressure Drugs Might Help Slow Alzheimer's: Study  
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... 2016 , ... The Dan Carlisle Agency, an Alabama-owned firm ... announcing the launch of a charity drive to raise support and awareness for ... children in Birmingham has grown steadily since the 1980’s, and the Pathways organization ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... to families and business owners in and around central Kansas, is joining the ... at-risk youth in the region. , Headquartered in Wichita, Youth Horizons works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand marijuana ... the Icahn School of Medicine at Mount Sinai has found. The study was ... children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite of ...
(Date:12/7/2016)... ... 07, 2016 , ... In the early morning of October 30, Newton County ... when he lost control of his patrol car. The vehicle overturned into an embankment, ... transported to Atlanta Medical Center, where he later succumbed to his injuries. Justin White ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  A new study by ... the use of opioid therapy to treat chronic pain ... likelihood of more harmful consequences, including death. ... and Zankhana Mehta , M.D., authored the study ... chronic opioid therapy. The study was published in the ...
(Date:12/8/2016)... NORWALK, Connecticut , 8. Dezember 2016 Mederi Therapeutics Inc ... Stretta-Therapie – eine nicht-operative Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in ... Reading ... Live ... by Professor Jun Liu, Director of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... According to the research report, the ... is expected to be worth US$9.7 bn by the end ... the forecast years of 2016 and 2024, the global market ... leading players operating in the global diabetes injection pens market ... Biocon Ltd., and Sanofi S.A. Transparency Market Research reports that ...
Breaking Medicine Technology: